Overview
Lynn Symonds is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Symonds has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Triple-Negative Breast Cancer. Dr. Symonds is currently accepting new patients.
Her clinical research consists of co-authoring 15 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
825 Eastlake Ave E, Seattle, WA 98109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwest Medical Specialties - Puyallup
Sibel Blau is an Oncologist in Puyallup, Washington. Dr. Blau is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, and Pleuropulmonary Blastoma. Dr. Blau is currently accepting new patients.
The Association Of University Physicians
Sara Hurvitz is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Hurvitz is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Metastatic Brain Tumor, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Hurvitz is currently accepting new patients.
Northwest Medical Specialties PLLC
Kyungsuk Jung is a Hematologist Oncology specialist and a Hospital Medicine provider in Tacoma, Washington. Dr. Jung is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Chronic Familial Neutropenia, Agranulocytosis, Severe Congenital Neutropenia, Colonoscopy, and Gastrostomy. Dr. Jung is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AngiosarcomaDr. Symonds isExperienced. Learn about Angiosarcoma.
- Breast CancerDr. Symonds isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Symonds isExperienced. Learn about Colorectal Cancer.
- Inflammatory Breast CancerDr. Symonds isExperienced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Symonds isExperienced. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Symonds isExperienced. Learn about Triple-Negative Breast Cancer.